{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8616876",
  "DateCompleted": {
    "Year": "1996",
    "Month": "06",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2006",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0008-5472",
      "JournalIssue": {
        "Volume": "56",
        "Issue": "9",
        "PubDate": {
          "Year": "1996",
          "Month": "May",
          "Day": "01"
        }
      },
      "Title": "Cancer research",
      "ISOAbbreviation": "Cancer Res"
    },
    "ArticleTitle": "K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.",
    "Pagination": {
      "StartPage": "2224",
      "EndPage": "2228",
      "MedlinePgn": "2224-8"
    },
    "Abstract": {
      "AbstractText": [
        "Atypical alveolar hyperplasia (AAH) is a potential precursor lesion from which lung adenocarcinomas arise and may be a good target for studying the early events of lung tumorigenesis. A common genetic alteration in lung adenocarcinomas is mutational activation of K-ras. To determine the timing of K-ras activation, we evaluated formalin-fixed and paraffin-embedded tissue samples of 41 AAHs and their paired lung neoplasms from 28 patients for codon 12 point mutations of the K-ras oncogene. K-ras codon 12 mutations were detected using PCR followed by allele-specific oligonucleotide hybridization. Mutations were found in 16 (39%) of the 41 AAHs, 8 (42%) of the 18 adenocarcinomas, and none (0%) of the 5 lung neoplasms that were not adenocarcinomas. Of the 18 patients with both an AAH and a synchronous lung adenocarcinoma, 6 had K-ras mutation in the adenocarcinoma but not in the AAH, 6 had mutations in the AAH but not in the adenocarcinoma, 4 did not harbor mutations in either the AAH or the adenocarcinoma, and 2 had mutations in both their AAH and their synchronous adenocarcinoma. In just 1 of the 18 patients was the same K-ras mutation present in the AAHs and adenocarcinoma of the patient. The detection of independent activating point mutations in a cancer-causing gene points to the neoplastic nature of AAH and suggests that glandular neoplasms of the lung arise from a background of field cancerization."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-6971, USA."
          }
        ],
        "LastName": "Westra",
        "ForeName": "W H",
        "Initials": "WH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Baas",
        "ForeName": "I O",
        "Initials": "IO"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hruban",
        "ForeName": "R H",
        "Initials": "RH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Askin",
        "ForeName": "F B",
        "Initials": "FB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wilson",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Offerhaus",
        "ForeName": "G J",
        "Initials": "GJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Slebos",
        "ForeName": "R J",
        "Initials": "RJ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cancer Res",
    "NlmUniqueID": "2984705R",
    "ISSNLinking": "0008-5472"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 3.6.5.2",
      "NameOfSubstance": "ras Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression Regulation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genes, ras"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hyperplasia"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Lung Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Point Mutation"
    },
    {
      "QualifierName": [
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Pulmonary Alveoli"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "ras Proteins"
    }
  ]
}